Home > Financial Ratios > MANGALAM DRUGS AND ORGANICS

MANGALAM DRUGS AND ORGANICS
EBIT Growth

    Back to All Ratios
MANGALAM DRUGS AND ORGANICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MANGALAM DRUGS AND ORGANICS
Please provide your vote to see the results

MANGALAM DRUGS AND ORGANICS Last 5 Year EBIT Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -81.15-61.00-20.37193.25472.52

What is the latest EBIT Growth ratio of MANGALAM DRUGS AND ORGANICS ?

The latest EBIT Growth ratio of MANGALAM DRUGS AND ORGANICS is -81.15 based on Mar2024 Standalone results.
Year EBIT Growth
Mar2024-81.15
Mar2023-61.00
Mar2022-20.37
Mar2021193.25
Mar2020472.52

How is EBIT Growth of MANGALAM DRUGS AND ORGANICS Trending?

Years EBIT Growth % Change
Mar2024 -81.15
Negative
Mar2023 -61
Negative
Mar2022 -20.37
Negative
Mar2021 193.25
-59.10
Mar2020 472.52 -

Other Financial Ratios of MANGALAM DRUGS AND ORGANICS


Compare EBIT Growth ratio of peers of MANGALAM DRUGS AND ORGANICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS ₹179.0 Cr -1.4% 6.1% 15.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


MANGALAM DRUGS AND ORGANICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS

-1.4%

6.1%

15.1%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses